This RCT was carried out in China, testing the efficacy of a clinical pharmacist-led smartphone application to improve medication adherence, insulin injection technique, and diabetes-related outcomes in a sample of women receiving insulin therapy. The gene discussed is INS; the disease is diabetes mellitus.